165 related articles for article (PubMed ID: 25510903)
1. Activin signalling and pre-eclampsia: from genetic risk to pre-symptomatic biomarker.
Williamson RD; O'Keeffe GW; Kenny LC
Cytokine; 2015 Feb; 71(2):360-5. PubMed ID: 25510903
[TBL] [Abstract][Full Text] [Related]
2. ACVR2A promoter polymorphism rs1424954 in the Activin-A signaling pathway in trophoblasts.
Thulluru HK; Michel OJ; Oudejans CB; van Dijk M
Placenta; 2015 Apr; 36(4):345-9. PubMed ID: 25659497
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of activin A signalling in a mouse model of pre-eclampsia.
Lim R; Adhikari S; Gurusinghe S; Leaw B; Acharya R; Rahman R; Ciayadi R; Potdar M; Kelso GF; Hearn MT; Wallace EM
Placenta; 2015 Aug; 36(8):926-31. PubMed ID: 26138362
[TBL] [Abstract][Full Text] [Related]
4. Pre-eclampsia with fetal growth restriction: placental and serum activin A and inhibin A levels.
Florio P; Ciarmela P; Luisi S; Palumbo MA; Lambert-Messerlian G; Severi FM; Petraglia F
Gynecol Endocrinol; 2002 Oct; 16(5):365-72. PubMed ID: 12587530
[TBL] [Abstract][Full Text] [Related]
5. [Activin and activin receptors in related gynecologic and obstetric diseases].
Li H; Huang F
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Aug; 35(8):896-902. PubMed ID: 20818087
[TBL] [Abstract][Full Text] [Related]
6. Maternal circulating levels of transforming growth factor-β superfamily and its soluble receptors in hypertensive disorders of pregnancy.
Xu YT; Shen MH; Jin AY; Li H; Zhu R
Int J Gynaecol Obstet; 2017 Jun; 137(3):246-252. PubMed ID: 28281288
[TBL] [Abstract][Full Text] [Related]
7. Serum and urine inhibin A but not free activin A are endocrine biomarkers of severe pre-eclampsia.
Hamar BD; Buhimschi IA; Sfakianaki AK; Pettker CM; Magloire LK; Funai EF; Copel JA; Buhimschi CS
Am J Obstet Gynecol; 2006 Dec; 195(6):1636-45. PubMed ID: 16959203
[TBL] [Abstract][Full Text] [Related]
8. High levels of activin A detected in preeclamptic placenta induce trophoblast cell apoptosis by promoting nodal signaling.
Yu L; Li D; Liao QP; Yang HX; Cao B; Fu G; Ye G; Bai Y; Wang H; Cui N; Liu M; Li YX; Li J; Peng C; Wang YL
J Clin Endocrinol Metab; 2012 Aug; 97(8):E1370-9. PubMed ID: 22685232
[TBL] [Abstract][Full Text] [Related]
9. Maternal serum inhibin-A and activin-A levels in the first trimester of pregnancies developing pre-eclampsia.
Spencer K; Cowans NJ; Nicolaides KH
Ultrasound Obstet Gynecol; 2008 Oct; 32(5):622-6. PubMed ID: 18816493
[TBL] [Abstract][Full Text] [Related]
10. TGF-beta superfamily expression and actions in the endometrium and placenta.
Jones RL; Stoikos C; Findlay JK; Salamonsen LA
Reproduction; 2006 Aug; 132(2):217-32. PubMed ID: 16885531
[TBL] [Abstract][Full Text] [Related]
11. Mutations in inhibin and activin genes associated with human disease.
Shelling AN
Mol Cell Endocrinol; 2012 Aug; 359(1-2):113-20. PubMed ID: 21827823
[TBL] [Abstract][Full Text] [Related]
12. Activin and NADPH-oxidase in preeclampsia: insights from in vitro and murine studies.
Lim R; Acharya R; Delpachitra P; Hobson S; Sobey CG; Drummond GR; Wallace EM
Am J Obstet Gynecol; 2015 Jan; 212(1):86.e1-12. PubMed ID: 25046804
[TBL] [Abstract][Full Text] [Related]
13. Maternal serum activin, inhibin, human chorionic gonadotrophin and alpha-fetoprotein as second trimester predictors of pre-eclampsia.
Davidson EJ; Riley SC; Roberts SA; Shearing CH; Groome NP; Martin CW
BJOG; 2003 Jan; 110(1):46-52. PubMed ID: 12504935
[TBL] [Abstract][Full Text] [Related]
14. Genetic association of the activin A receptor gene (ACVR2A) and pre-eclampsia.
Fitzpatrick E; Johnson MP; Dyer TD; Forrest S; Elliott K; Blangero J; Brennecke SP; Moses EK
Mol Hum Reprod; 2009 Mar; 15(3):195-204. PubMed ID: 19126782
[TBL] [Abstract][Full Text] [Related]
15. Pre-eclampsia: contribution of maternal constitutional factors and the consequences for cardiovascular health.
Barden A
Clin Exp Pharmacol Physiol; 2006 Sep; 33(9):826-30. PubMed ID: 16922815
[TBL] [Abstract][Full Text] [Related]
16. Oxidative stress increases placental and endothelial cell activin A secretion.
Mandang S; Manuelpillai U; Wallace EM
J Endocrinol; 2007 Mar; 192(3):485-93. PubMed ID: 17332518
[TBL] [Abstract][Full Text] [Related]
17. Genome-wide expression profiling of placentas in the p57Kip2 model of pre-eclampsia.
Knox KS; Baker JC
Mol Hum Reprod; 2007 Apr; 13(4):251-63. PubMed ID: 17289831
[TBL] [Abstract][Full Text] [Related]
18. First-trimester maternal serum activin A in pre-eclampsia and fetal growth restriction.
Ong CY; Liao AW; Munim S; Spencer K; Nicolaides KH
J Matern Fetal Neonatal Med; 2004 Mar; 15(3):176-80. PubMed ID: 15280143
[TBL] [Abstract][Full Text] [Related]
19. Maternal serum activin A levels in association with intrauterine fetal growth restriction.
Wallace EM; Schneider-Kolsky ME; Edwards A; Baker L; Jenkin G
BJOG; 2003 Mar; 110(3):306-10. PubMed ID: 12628273
[TBL] [Abstract][Full Text] [Related]
20. Contribution of fetal ANXA5 gene promoter polymorphisms to the onset of pre-eclampsia.
Ota S; Miyamura H; Nishizawa H; Inagaki H; Inagaki A; Inuzuka H; Suzuki M; Miyazaki J; Sekiya T; Udagawa Y; Kurahashi H
Placenta; 2013 Dec; 34(12):1202-10. PubMed ID: 24140079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
